会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Novel human galectins
    • 新型人类galectins
    • US20020127689A1
    • 2002-09-12
    • US09894526
    • 2001-06-27
    • Incyte Pharmaceuticals, Inc.
    • Jennifer L. HillmanSurya K. GoliOlga BandmanPhillip R. HawkinsJoanne R. Petithory
    • C12N009/24C07H021/04C12P021/02C12N005/06A01K067/00C12N001/21
    • C07K14/4726A61K38/00
    • The present invention provides two novel human galectins (designated individually as GAL-5HA and GAL-5HB, and collectively as GAL-5H) and polynucleotides which identify and encode GAL-5H. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding GAL-5H and a method for producing GAL-5H. The invention also provides for use of GAL-5H and agonists, antibodies, or antagonists specifically binding GAL-5H, in the prevention and treatment of diseases associated with expression of GAL-5H. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding GAL-5H for the treatment of diseases associated with the expression of GAL-5H. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding GAL-5H.
    • 本发明提供两种新型人半乳凝素(单独命名为GAL-5HA和GAL-5HB,统称为GAL-5H)和识别和编码GAL-5H的多核苷酸。 本发明还提供了遗传工程改造的表达载体和宿主细胞,其包含编码GAL-5H的核酸序列和产生GAL-5H的方法。 本发明还提供使用GAL-5H和特异性结合GAL-5H的激动剂,抗体或拮抗剂来预防和治疗与GAL-5H表达相关的疾病。 另外,本发明提供了反义分子用于编码GAL-5H的多核苷酸用于治疗与GAL-5H表达相关的疾病的用途。 本发明还提供利用多核苷酸或其片段或其补体以及特异性结合GAL-5H的抗体的诊断测定法。
    • 4. 发明申请
    • Human SQM1 protein homolog
    • 人类SQM1蛋白同源物
    • US20020106737A1
    • 2002-08-08
    • US09962021
    • 2001-09-21
    • Incyte Pharmaceuticals, Inc.
    • Jennifer L. HillmanSurya K. Goli
    • C07H021/04C12P021/02C12N005/06C07K014/78
    • C07K14/705A61K38/00
    • The present invention provides a polynucleotide which identifies and encodes a novel human SQM2. The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding human SQM2. The invention also provides for the use of purified SQM2 and its agonists in the production of recombinant proteins and in pharmaceutical compositions for the treatment of diseases associated with the expression of SQM2. Additionally, the invention provides for the use of SQM2 antagonists and inhibitors, including antisense molecules to SQM2 polynucleotides (i.e., gene sequences) in pharmaceutical compositions for the treatment of diseases associated with the expression of SQM2. The invention also describes diagnostic assays which utilize the polynucleotide to hybridize with the transcripts and/or genomic DNA encoding SQM2 and anti-human SQM2 antibodies which specifically bind to SQM2.
    • 本发明提供鉴定和编码新型人SQM2的多核苷酸。 本发明提供了包含编码人SQM2的核酸序列的遗传工程表达载体和宿主细胞。 本发明还提供纯化的SQM2及其激动剂在生产重组蛋白质和用于治疗与SQM2表达相关的疾病的药物组合物中的用途。 另外,本发明提供SQM2拮抗剂和抑制剂的用途,包括用于治疗与SQM2表达相关的疾病的药物组合物中的SQM2多核苷酸(即基因序列)的反义分子。 本发明还描述了利用多核苷酸与编码SQM2的转录物和/或基因组DNA和特异性结合SQM2的抗人SQM2抗体杂交的诊断测定法。
    • 6. 发明申请
    • Human apoptosis-related calcium-binding protein
    • 人类凋亡相关钙结合蛋白
    • US20020086830A1
    • 2002-07-04
    • US09969836
    • 2001-10-01
    • Incyte Pharmaceuticals, Inc.
    • Jennifer L. HillmanSurya K. Goli
    • A01K067/00A61K038/17C07H021/04C12N009/64C12P021/02C12N005/06C12N001/21
    • C07K14/4747A61K38/00C07K14/4702
    • The present invention provides a human apoptosis-related calcium-binding protein (HARC) and polynucleotides which identify and encode HARC. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HARC and a method for producing HARC. The invention also provides for agonists, antibodies, or antagonists specifically binding HARC, and their use, in the prevention and treatment of diseases associated with expression of HARC. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HARC for the treatment of diseases associated with the expression of HARC. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HARC.
    • 本发明提供了人凋亡相关的钙结合蛋白(HARC)和识别和编码HARC的多核苷酸。 本发明还提供了遗传工程改造的表达载体和宿主细胞,其包含编码HARC的核酸序列和用于产生HARC的方法。 本发明还提供了特异性结合HARC的激动剂,抗体或拮抗剂及其在预防和治疗与HARC表达相关的疾病中的用途。 另外,本发明提供反义分子用于编码HARC的多核苷酸用于治疗与HARC表达相关的疾病。 本发明还提供利用多核苷酸或其片段或其补体以及特异性结合HARC的抗体的诊断测定法。
    • 10. 发明申请
    • Novel human transmembrane 4 superfamily protein
    • 新型人类跨膜4超家族蛋白
    • US20030147893A1
    • 2003-08-07
    • US09970424
    • 2001-10-02
    • Incyte Pharmaceuticals, Inc
    • Jennifer L. HillmanSurya K. Goli
    • A01K067/00C12Q001/68G01N033/574A61K039/395C12P021/02C12N005/06C07K014/47C07H021/04
    • C07K14/70596A61K38/00
    • The present invention provides a novel human integral membrane (TMP-1) and polynucleotides which identify and encode TMP-1. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding TMP-1 and a method for producing TMP-1. The invention also provides for agonists, antibodies, or antagonists specifically binding TMP-1, and their use, in the prevention and treatment of diseases associated with expression of TMP-1. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding TMP-1 for the treatment of diseases associated with the expression of TMP-1. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding TMP-1.
    • 本发明提供一种新型人体内膜(TMP-1)和识别和编码TMP-1的多核苷酸。 本发明还提供了包含编码TMP-1的核酸序列的基因工程表达载体和宿主细胞以及产生TMP-1的方法。 本发明还提供了特异性结合TMP-1的激动剂,抗体或拮抗剂及其在预防和治疗与TMP-1表达相关的疾病中的用途。 此外,本发明提供了将反义分子用于编码TMP-1的多核苷酸用于治疗与TMP-1表达相关的疾病的用途。 本发明还提供利用多核苷酸或其片段或其补体以及特异性结合TMP-1的抗体的诊断测定法。